The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis
Abstract Background Although accumulating data have suggested the development of cancer in systemic lupus erythematosus (SLE) patients, these results remain inconsistent. To examine such a putative association, this analysis reports the association between SLE and the risks of 24 cancer types. Metho...
Main Authors: | Lebin Song, Yi Wang, Jiayi Zhang, Ninghong Song, Xiaoyun Xu, Yan Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13075-018-1760-3 |
Similar Items
-
Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE)
by: Gabriella Moroni, et al.
Published: (2010-01-01) -
Safety and efficacy of biological agents in the treatment of Systemic Lupus Erythematosus (SLE)
by: Justin Chan, et al.
Published: (2023-10-01) -
Efficacy of baricitinib in the treatment of Systemic lupus erythematosus (SLE): A Systemic review and meta-analysis
by: Syed Muhammad Mehdi Zaidi, et al.
Published: (2023-12-01) -
Interferon alpha (IFN-α) in systemic lupus erythematosus (SLE)
by: Sara Moqbil, et al.
Published: (2022-11-01) -
A Case of Systemic Lupus Erythematosus with Cutaneous Leukocytoclastic Vasculitis Mimicking Bullous SLE
by: Fumi Miyagawa, et al.
Published: (2021-09-01)